Neuspera Medical Announces 2nd Phase of Sans-UUI IDE Clinical Trial with the Nuvella

The study will evaluate the safety and efficacy of Neuspera’s Nuvella system designed to treat overactive bladder (OAB) for patients with urinary urgency incontinence (UUI) symptoms.